Chromatin Bioscience Signs Collaboration Agreement with Astellas
![]() |
EDINBURGH, Scotland, April 14, 2025 /PRNewswire/ -- Chromatin Bioscience, a leader in the design of synthetic promoters and gene control systems, is pleased to announce a collaboration agreement with Astellas Pharma, a global life sciences company.
Under the agreement, Chromatin Bioscience will use its proprietary chromatinLENS platform to...
Read more: Chromatin Bioscience Signs Collaboration Agreement with Astellas





